HYLAFEMBORICUM ACIDUM 2X (US Pharmaceutical Corporation)


Welcome to the PulseAid listing for the HYLAFEM drug offered from US Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: US Pharmaceutical Corporation
NON-PROPRIETARY NAME: Boricum Acidum
SUBSTANCE NAME: BORIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: VAGINAL
DOSAGE FORM: SUPPOSITORY
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-12-31
END MARKETING DATE: 0000-00-00


HYLAFEM BORICUM ACIDUM 2X HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHYLAFEM BORICUM ACIDUM 2X from US Pharmaceutical Corporation
LABELER NAME: US Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 2([hp_X]/1)
START MARKETING DATE: 2015-12-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52747-250_7f411135-9493-4d1f-b956-bf0057480363
PRODUCT NDC: 52747-250
APPLICATION NUMBER:

Other BORIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rxhomeo Private Limited d.b.a. Rxhomeo, IncBORICUM ACIDUM
SPAI-SONS PHARMACEUTICAL INTERNATIONAL COSMETICSGYNOX-SOFT
US Pharmaceutical CorporationHYLAFEM
Washington Homeopathic ProductsBoricum acidum